SG11202004260YA - Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives - Google Patents

Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives

Info

Publication number
SG11202004260YA
SG11202004260YA SG11202004260YA SG11202004260YA SG11202004260YA SG 11202004260Y A SG11202004260Y A SG 11202004260YA SG 11202004260Y A SG11202004260Y A SG 11202004260YA SG 11202004260Y A SG11202004260Y A SG 11202004260YA SG 11202004260Y A SG11202004260Y A SG 11202004260YA
Authority
SG
Singapore
Prior art keywords
antihelmintic
quinoline
amino
preparing
carboxamide derivatives
Prior art date
Application number
SG11202004260YA
Other languages
English (en)
Inventor
Florian Erver
Frank Memmel
Thomas Himmler
Andreas Steib
Marc Nowakowski
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of SG11202004260YA publication Critical patent/SG11202004260YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44Palladium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
SG11202004260YA 2017-12-15 2018-12-14 Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives SG11202004260YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17207586 2017-12-15
PCT/EP2018/084964 WO2019115768A1 (en) 2017-12-15 2018-12-14 Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives

Publications (1)

Publication Number Publication Date
SG11202004260YA true SG11202004260YA (en) 2020-06-29

Family

ID=60673654

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202004260YA SG11202004260YA (en) 2017-12-15 2018-12-14 Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives

Country Status (18)

Country Link
US (1) US11505544B2 (ko)
EP (1) EP3692037A1 (ko)
JP (1) JP2021506774A (ko)
KR (1) KR20200099548A (ko)
CN (1) CN111448192B (ko)
AU (1) AU2018382999B2 (ko)
BR (1) BR112020011901A2 (ko)
CA (1) CA3085675A1 (ko)
CL (1) CL2020001589A1 (ko)
CO (1) CO2020007222A2 (ko)
DO (1) DOP2020000118A (ko)
IL (1) IL275216A (ko)
MX (1) MX2020006185A (ko)
PH (1) PH12020550905A1 (ko)
SG (1) SG11202004260YA (ko)
TW (1) TWI809018B (ko)
UY (1) UY38009A (ko)
WO (1) WO2019115768A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113825543A (zh) 2019-03-19 2021-12-21 勃林格殷格翰动物保健美国公司 驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物
JP2023521342A (ja) * 2020-04-09 2023-05-24 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 駆虫性化合物としての置換縮合アジン類
PE20231205A1 (es) 2020-05-29 2023-08-17 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos como anthelminticos
EP4148052A1 (en) * 2021-09-09 2023-03-15 Bayer Animal Health GmbH New quinoline derivatives
AR127495A1 (es) 2021-11-01 2024-01-31 Boehringer Ingelheim Vetmedica Gmbh Compuestos de pirrolopiridazina como antihelmínticos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2309882A1 (en) * 1997-12-22 1999-07-01 Pharmacia & Upjohn Company 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
US6787534B2 (en) 1999-12-28 2004-09-07 Eisai Co., Ltd. Sulfonamide-containing heterocyclic compounds
JP4039856B2 (ja) 2000-02-03 2008-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 インテグリン発現阻害剤
JP2008214323A (ja) 2007-03-08 2008-09-18 Kyowa Hakko Kogyo Co Ltd 皮膚疾患の治療及び/または予防剤
AR089939A1 (es) 2012-02-09 2014-10-01 Glenmark Pharmaceuticals Sa COMPUESTOS BICICLICOS COMO INHIBIDORES DE mPGES-1
AR098475A1 (es) * 2013-11-26 2016-06-01 Bayer Cropscience Ag Compuestos pesticidas y usos
NZ724691A (en) * 2014-03-24 2018-02-23 Guangdong Zhongsheng Pharmaceutical Co Ltd Quinoline derivatives as smo inhibitors
RU2018126105A (ru) 2015-12-17 2020-01-17 Астекс Терапьютикс Лимитед Хинолин-3-карбоксамиды в качестве ингибиторов h-pgds
MX2019005569A (es) * 2016-11-11 2019-09-05 Bayer Animal Health Gmbh Nuevos derivados de quinolina.

Also Published As

Publication number Publication date
TWI809018B (zh) 2023-07-21
TW201927773A (zh) 2019-07-16
DOP2020000118A (es) 2020-08-31
UY38009A (es) 2019-07-31
CN111448192B (zh) 2024-04-12
CN111448192A (zh) 2020-07-24
RU2020123282A (ru) 2022-01-17
MX2020006185A (es) 2020-09-03
KR20200099548A (ko) 2020-08-24
US11505544B2 (en) 2022-11-22
CO2020007222A2 (es) 2020-11-20
BR112020011901A2 (pt) 2020-11-24
AU2018382999B2 (en) 2023-11-23
CL2020001589A1 (es) 2020-11-20
AU2018382999A1 (en) 2020-05-28
JP2021506774A (ja) 2021-02-22
EP3692037A1 (en) 2020-08-12
CA3085675A1 (en) 2019-06-20
PH12020550905A1 (en) 2021-05-17
US20200308153A1 (en) 2020-10-01
IL275216A (en) 2020-07-30
WO2019115768A1 (en) 2019-06-20

Similar Documents

Publication Publication Date Title
ZA201708142B (en) Process for preparing 4-amino-pyridazines
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
IL274439A (en) Process for making Tapinaroff
IL275216A (en) A process for the preparation of anthelmintic 4-aminoquinoline-3-carboxamide
PT3429998T (pt) Processo para preparação de derivados de quinolin-2-il-fenilamina e seus sais
PL3526229T3 (pl) Sposób wytwarzania glukopiranozylo-podstawionych pochodnych benzylo-benzenu
IL292429B1 (en) An improved process for the preparation of aminopyrimidine derivatives
HK1245792A1 (zh) 製備α-甲酰胺吡咯烷衍生物的方法
HUE053818T2 (hu) Eljárás HMF elõállítására
IL253877B (en) Process for the preparation of 3-chloro-2-vinylphenylsulfonates
IL248565A0 (en) A process for the preparation of thiazole derivatives
ZA201908452B (en) Improved process for preparing imetelstat
PL3573988T3 (pl) Sposób wytwarzania pochodnych puryny
IL248568A0 (en) A process for the preparation of dihydroisoxazole derivatives
IL273695A (en) A process for preparing Spiro histories
IL273639A (en) A process for the preparation of pyrrolidine alpha-carboxamide derivatives
IL271512B (en) A method for the preparation of modified 4-aminoindan derivatives
IL253630B (en) A process for the preparation of modified phenylisoxazoline derivatives
GB201709297D0 (en) Method for preparing methylprrolidones
GB201414880D0 (en) Process for making phosphate derivatives